0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Comprehensive analysis of the endothelin system in the kidneys of mice, rats, and humans

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The intrarenal endothelin (ET) system is an established moderator of kidney physiology and mechanistic contributor to the pathophysiology and progression of chronic kidney disease in humans and rodents. The aim of the present study was to characterize ET system by combining single cell RNA sequencing (scRNA-seq) data with immunolocalization in human and rodent kidneys of both sexes. Using publicly available scRNA-seq data, we assessed sex and kidney disease status (human), age and sex (rats), and diurnal expression (mice) on the kidney ET system expression. In normal human biopsies of both sexes and in rodent kidney samples, the endothelin-converting enzyme-1 (ECE1) and ET-1 were prominent in the glomeruli and endothelium. These data agreed with the scRNA-seq data from these three species, with ECE1/Ece1 mRNA enriched in the endothelium. However, the EDN1/Edn1 gene (encodes ET-1) was rarely detected, even though it was immunolocalized within the kidneys, and plasma and urinary ET-1 excretion are easily measured. Within each species, there were some sex-specific differences. For example, in kidney biopsies from living donors, men had a greater glomerular endothelial cell endothelin receptor B ( Ednrb) compared with women. In mice, females had greater kidney endothelial cell Ednrb than male mice. As commercially available antibodies did not work in all species, and RNA expression did not always correlate with protein levels, multiple approaches should be considered to maintain required rigor and reproducibility of the pre- and clinical studies evaluating the intrarenal ET system.

          Related collections

          Most cited references89

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Eleven grand challenges in single-cell data science

          The recent boom in microfluidics and combinatorial indexing strategies, combined with low sequencing costs, has empowered single-cell sequencing technology. Thousands—or even millions—of cells analyzed in a single experiment amount to a data revolution in single-cell biology and pose unique data science problems. Here, we outline eleven challenges that will be central to bringing this emerging field of single-cell data science forward. For each challenge, we highlight motivating research questions, review prior work, and formulate open problems. This compendium is for established researchers, newcomers, and students alike, highlighting interesting and rewarding problems for the coming years.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk

            Blood pressure (BP) is a heritable trait 1 influenced by multiple biological pathways and is responsive to environmental stimuli. Over one billion people worldwide have hypertension (BP ≥140 mm Hg systolic [SBP] or ≥90 mm Hg diastolic [DBP]) 2 . Even small increments in BP are associated with increased risk of cardiovascular events 3 . This genome-wide association study of SBP and DBP, which used a multi-stage design in 200,000 individuals of European descent, identified 16 novel loci: six of these loci contain genes previously known or suspected to regulate BP (GUCY1A3-GUCY1B3; NPR3-C5orf23; ADM; FURIN-FES; GOSR2; GNAS-EDN3); the other 10 provide new clues to BP physiology. A genetic risk score based on 29 genome-wide significant variants was associated with hypertension, left ventricular wall thickness, stroke, and coronary artery disease, but not kidney disease or kidney function. We also observed associations with BP in East Asian, South Asian, and African ancestry individuals. Our findings provide new insights into the genetics and biology of BP, and suggest novel potential therapeutic pathways for cardiovascular disease prevention.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Endothelin

              The endothelins comprise three structurally similar 21-amino acid peptides. Endothelin-1 and -2 activate two G-protein coupled receptors, ETA and ETB, with equal affinity, whereas endothelin-3 has a lower affinity for the ETA subtype. Genes encoding the peptides are present only among vertebrates. The ligand-receptor signaling pathway is a vertebrate innovation and may reflect the evolution of endothelin-1 as the most potent vasoconstrictor in the human cardiovascular system with remarkably long lasting action. Highly selective peptide ETA and ETB antagonists and ETB agonists together with radiolabeled analogs have accurately delineated endothelin pharmacology in humans and animal models, although surprisingly no ETA agonist has been discovered. ET antagonists (bosentan, ambrisentan) have revolutionized the treatment of pulmonary arterial hypertension, with the next generation of antagonists exhibiting improved efficacy (macitentan). Clinical trials continue to explore new applications, particularly in renal failure and for reducing proteinuria in diabetic nephropathy. Translational studies suggest a potential benefit of ETB agonists in chemotherapy and neuroprotection. However, demonstrating clinical efficacy of combined inhibitors of the endothelin converting enzyme and neutral endopeptidase has proved elusive. Over 28 genetic modifications have been made to the ET system in mice through global or cell-specific knockouts, knock ins, or alterations in gene expression of endothelin ligands or their target receptors. These studies have identified key roles for the endothelin isoforms and new therapeutic targets in development, fluid-electrolyte homeostasis, and cardiovascular and neuronal function. For the future, novel pharmacological strategies are emerging via small molecule epigenetic modulators, biologicals such as ETB monoclonal antibodies and the potential of signaling pathway biased agonists and antagonists.
                Bookmark

                Author and article information

                Contributors
                Role: Formal analysisRole: Writing—original draftRole: Writing—review & editing
                Role: Formal analysisRole: Writing—original draftRole: Writing—review & editing
                Role: ConceptualizationRole: ResourcesRole: Data curationRole: Formal analysisRole: SupervisionRole: Funding acquisitionRole: ValidationRole: InvestigationRole: VisualizationRole: Writing—original draftRole: Project administrationRole: Writing—review & editing
                Role: ConceptualizationRole: ResourcesRole: Data curationRole: Formal analysisRole: SupervisionRole: Funding acquisitionRole: ValidationRole: InvestigationRole: VisualizationRole: MethodologyRole: Writing—original draftRole: Project administrationRole: Writing—review & editing
                Journal
                Biosci Rep
                Biosci Rep
                bsr
                Bioscience Reports
                Portland Press Ltd.
                0144-8463
                1573-4935
                31 July 2024
                12 July 2024
                : 44
                : 7
                : BSR20240768
                Affiliations
                [1 ]Department of Medicine, Division of Nephrology, Section of Cardio-Renal Physiology and Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, U.K.
                [2 ]Department of Pediatrics, Division of Hematology-Oncology, Section of Cardio-Renal Physiology and Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, U.K.
                Author notes
                Correspondence: Kelly A. Hyndman ( kellyhyndman@ 123456uabmc.edu )
                [*]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0002-8465-2588
                Article
                BSR20240768
                10.1042/BSR20240768
                11249498
                38904098
                a05bd118-730d-4ea7-9c28-4da873430631
                © 2024 The Author(s).

                This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).

                History
                : 18 June 2024
                : 20 June 2024
                : 20 June 2024
                : 21 June 2024
                Page count
                Pages: 19
                Funding
                Funded by: National Heart, Lung, and Blood Institute (NHLBI), doi 100000050;
                Award ID: K99/R00HL144817
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), doi 100000062;
                Award ID: R01DK126664
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), doi 100000062;
                Award ID: R01DK128001
                Categories
                Cardiovascular System & Vascular Biology
                RNA
                Translational Science
                Gastrointestinal, Renal & Hepatic Systems
                Research Articles

                Life sciences
                chronic kidney disease,endothelin,kidney,protein,rna,sex
                Life sciences
                chronic kidney disease, endothelin, kidney, protein, rna, sex

                Comments

                Comment on this article